>

Establishment Labs Profile

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:6em;padding-top: 0px;;'>E</div>

Performance

5 / 100

Odds of Distress

11
Analyze Filter   Earning Report: March 18, 2020
Equity ratings for Establishment Labs Holdings are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 21, 2019 and ending today February 19, 2020. Click here to learn more.

Establishment Labs Profile

Upcoming quarterly earning report is expected on March 18, 2020. Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic plastic surgery and reconstructive plastic surgery. Establishment Labs Holdings Inc. was founded in 2004 and is headquartered in Alajuela, Costa Rica. Establishment Labs operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 596 people. more on Establishment Labs
Establishment Labs Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
Establishment Labs SEC Filings
Establishment Labs SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameEstablishment Labs Holdings
CEO, DirectorJuan QuirosView All
Thematic Classification
Currently Active Investing Idea
  Medical Equipment
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Establishment Labs
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Establishment Labs ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Debt to Equity Ratio
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of Establishment Labs representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
EBITDA Margin
Gross Margin
Profit Margin
Establishment Labs Holdings (ESTA) is traded on BATS Exchange in USA. It is located in Buildings B15 and 25 and employs 596 people. Establishment Labs is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 561.98 M. Establishment Labs conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 20.6 M outstanding shares of which 729.27 K shares are currently shorted by private and institutional investors with about 4.74 trading days to cover. The company currently holds about 42.56 M in cash with (34.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.07.
Check Establishment Labs Probability Of Bankruptcy

Ownership Allocation (%)

Establishment Labs Target Price Odds Analysis

Odds Below 24.65HorizonTargetOdds Above 24.65
13.26%30 days 24.65 86.62%
Based on normal probability distribution, the odds of Establishment Labs to move above current price in 30 days from now is about 86.62 (This Establishment Labs Holdings probability density function shows the probability of Establishment Labs Stock to fall within a particular range of prices over 30 days) .

Establishment Labs Top Holders

Establishment Labs Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Jw Asset Management LlcCommon Shares3.1 M86.2 M
Rtw Investments LpCommon SharesM56.2 M
View Establishment Labs Diagnostics

Establishment Labs Holdings Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Establishment Labs Against Markets

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Establishment Labs Upcoming and Recent Events

Establishment Labs Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportMarch 18, 2020
Next Earnings ReportMay 20, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndMarch 18, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Establishment Labs Corporate Filings

Establishment Labs SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Other Events. Entry into a Material Definitive Agreement

Establishment Labs Corporate Directors

David Hung Independent Director
Lisa Gersh Independent Director
Nicholas Lewin Independent Director
Continue to Investing Opportunities. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.
Company logos by clearbit